Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Third Rock's Eleven pitches a $69M IPO to fuel its PhIII dry eye program
Third Rock's Eleven pitches a $69M IPO to fuel its PhIII dry eye program
Third Rock's Eleven pitches a $69M IPO to fuel its PhIII dry eye program
Submitted by
admin
on December 31, 2013 - 11:40am
Source:
Fierce Biotech
News Tags:
dry eye disease
Third Rock
IPOs
Eleven Biotherapeutics
Headline:
Third Rock's Eleven pitches a $69M IPO to fuel its PhIII dry eye program
Do Not Allow Advertisers to Use My Personal information
